188 related articles for article (PubMed ID: 24040850)
1. Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.
Hachiken H; Murai A; Wada K; Kuwahara T; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2013 Oct; 51(10):807-15. PubMed ID: 24040850
[TBL] [Abstract][Full Text] [Related]
2. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
Takada M; Fukumoto K; Shibakawa M
J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
[TBL] [Abstract][Full Text] [Related]
3. Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin.
Takada M; Fujimoto M; Hosomi K
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):181-91. PubMed ID: 24472400
[TBL] [Abstract][Full Text] [Related]
4. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.
Hirata Y; Kataoka H; Shimura T; Mizushima T; Mizoshita T; Tanida S; Kamiya T; Joh T
Scand J Gastroenterol; 2011 Jul; 46(7-8):803-9. PubMed ID: 21501103
[TBL] [Abstract][Full Text] [Related]
5. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
[TBL] [Abstract][Full Text] [Related]
6. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
7. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
9. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
10. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
[TBL] [Abstract][Full Text] [Related]
14. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis.
Szabó IL; Mátics R; Hegyi P; Garami A; Illés A; Sarlós P; Bajor J; Szűcs A; Mosztbacher D; Márta K; Szemes K; Csekő K; Kővári B; Rumbus Z; Vincze Á
J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055
[TBL] [Abstract][Full Text] [Related]
15. Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries.
Fujita T; Kutsumi H; Sanuki T; Hayakumo T; Azuma T
J Gastroenterol; 2013 May; 48(5):559-73. PubMed ID: 23460386
[TBL] [Abstract][Full Text] [Related]
16. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
17. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
[TBL] [Abstract][Full Text] [Related]
18. PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis.
Mo C; Sun G; Wang YZ; Lu ML; Yang YS
PLoS One; 2015; 10(7):e0131558. PubMed ID: 26147767
[TBL] [Abstract][Full Text] [Related]
19. The aspirin cardiovascular/gastrointestinal risk calculator--a tool to aid clinicians in practice.
Lanas A; Polo-Tomás M; Casado-Arroyo R
Aliment Pharmacol Ther; 2013 Apr; 37(7):738-48. PubMed ID: 23413984
[TBL] [Abstract][Full Text] [Related]
20. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.
Suh DC; Hunsche E; Shin HC; Mavros P
Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
